glp 1 anorexia nervosa Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis Beyond weight loss: Integrating GLP-1

GLP-1 medications can disrupt electrolyte balance through nausea and reduced appetite

Clinical Evidence for GLP-1 Receptor Agonists in Alzheimers Disease. PubMed Cheng HW et al

Although use of glucagon-like peptide-1 agonists for diabetes and weight loss has soared with indications now expanding into liver diseases, specifically metabolic dysfunction-associated steatohepatitis, the jury is still out on its benefit.With the recent FDA approval of Rezdiffra (resmetirom, Madrigal Pharmaceuticals) for the treatment for MASH, the question is whether (and how) GLP-1s will fit

GLP-1 drugs curb appetite, but raise protein needs

PlexusDx explains how these medications work, their clinical effectiveness, and whether tablet form is right for your health goals